baek kim

Breast cancer surgeon, keen cook, cyclist, basketball and piano player

[Jon Lund @Schoolofsurg]

Do surgical curricula deliver a day 1 consultant or do new CCT holders find they need to do a fellowship?
If so, why? To meet person spec of cons job or to gain confidence or other?
If there is a gap, which specialties is it widest in?
@ASiTofficial @bota_uk

[Scholarship for PhD @ScholarshipfPhd]

Writing a scientific article: A Step-by-Step Guide for Beginners (1/7)

[BJS @BJSurgery]

#systematicreview of targeted axillary dissection in node-positive #breastcancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement
➡️ https://t.co/ufRez3Dz3j

In node-positive (cN+) breast cancer treated with neoadjuvant systemic therapy, combining sentinel lymph node biopsy and targeted lymph node (TLN) excision (targeted axillary dissection, TAD) increases accuracy. TAD procedures differ in terms of the TLN excision technique.
This systematic review aimed to provide an overview of TAD procedures regarding definitive marker type and timing of placement.
Owing to study heterogeneity, the optimal technique could not be determined. High-quality prospective studies reporting all relevant aspects of TAD are needed.

Great work by Sabine R de Wild, Linetta B Koppert, Thiemo J A van Nijnatten, Loes F S Kooreman, Marie-Jeanne T F D Vrancken Peeters, Marjolein L Smidt, Janine M Simons

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @des_winter @evanscolorectal @robhinchliffe1 @bplwijn @ksoreide @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol

[bobresource @bobresource]

Tailor X? ZO11? CREATE-X? How well do you know your major breast cancer trials? Take a look at the key trials on BOB! https://t.co/1hGEnh2owD #BreastCancerResearch #BOBResource

[MAMMAaudit @MammAaudit]

📢Pleased to announce our paper has been published in @BJSurgery 🥳👏Check it out here: https://t.co/jCQ3AP7t08 Well done and many thanks to all our collaborators @ABSGBI @TheMammaryFold1 @MFoldResearch 🤩👍

[ABS @ABSGBI]

Do you have a research idea but need some funding to get it started? We are offering Research Development Grants of up to £10,000. Find out more and apply by 8/9/23: https://t.co/YR0uPaRDdb

[NAoPri @NAoPri_news]

❔ Interested in an opportunity to work as a Clinical Fellow on the two new #audits of #breastcancer @NATCAN_news ❔
Check out this link & apply by 28-Feb: https://t.co/niU4cbXZhZ
@ABSGBI @RCSnews @RCRadiologists @TheMammaryFold1 @BreastCancerNow #UKBCG

[ABS @ABSGBI]

Hear Dr Nisha Sharma's keynote lecture on Innovation in Breast Cancer Diagnosis and Treatment at the iBRA NET & MFAC Research Day at the RSM in London on the 6th February. Register now! https://t.co/YSpamqqvqe #associationofbreastsurgery #researchday #breastcancer

[The Mammary Fold @TheMammaryFold1]

28 units have registered for the Breast ONC Collaborative study organised by @MFoldResearch 👏

This innovative study will examine regional variation in oncoplastic training

A reminder to those who signed up to please input your data (on REDCap) by the end of January!

[BJS @BJSurgery]

Open Access in December's BJS: Antibiotic prophylaxis in breast cancer surgery (PAUS trial) https://t.co/fHqoq5K1k0 @bplwijn @des_winter @ksoreide @MalinASund @evanscolorectal @nfmkok @paulo_sutt @robhinchliffe1 @young_bjs

[Yazan MASANNAT 🇯🇴🇬🇧 @YMasannat]

Dear all please check and share the @weare_iBRANET and @MFoldResearch research meeting on the 6th of February
The link for registering is in the tweet below
@Rachelleexn @askanushka @DrSarahTang @DrFionaTsang @kfgomez8 @iBreastSurgeon @iBreastBook @1LondonBreast

[The Mammary Fold @TheMammaryFold1]

Don't miss the chest wall perforator flaps masterclass next week organised by @PGRoy8 and @RoySocMed

Free for members and non-members

Tuesday 13th Deember 6pm

https://t.co/xXXMAtYkut

[ABS @ABSGBI]

Evaluation of histological pattern of residual tumour after neoadjuvant chemotherapy shows that scattered residual tumour pattern resulted in worse relapse free and overall survival.
https://t.co/VhZWrUv49g

[The Mammary Fold @TheMammaryFold1]

The joint @weare_iBRANET & @MFoldResearch Research Day will be held in London 6th Feb 2023

Registration is only £25.

Abstract submission deadline is the 6th of January

More details here:

https://t.co/n8d4v4x5hY

[ABS @ABSGBI]

Major surgical complications after breast cancer surgery are associated with worse survival outcomes, especially after mastectomy, highlighting the importance of surgical de-escalation.
https://t.co/RHHhuGQbrf

[ABS @ABSGBI]

If you have a trial idea or a research proposal that you would like to present at the next ABS Research Sandpit session, please email [email protected] to secure your slot. The Sandpit will be held virtually on 13.12.2022, 2-4pm.
More info here: https://t.co/szFGP7ECA7

[The Mammary Fold @TheMammaryFold1]

BreaST ONCA is Live!

This National Collaborative Trainees Audit coordinated by @MFoldResearch will be assessing regional variation in oncoplastic breast surgery training.

Data collection phase ends 31/12/22

Sign up to be a collaborator today!

https://t.co/SvQ7LsDa4I

[Annals of Surgical Oncology @AnnSurgOncol]

NOVEMBER ISSUE: Impact of the Histologic Pattern of #ResidualTumor After #NeoadjuvantChemotherapy on Recurrence and Survival in Stage I–III #BreastCancer. https://t.co/i4zjGkbkY0 @McMastersKelly @SocSurgOnc

[BJS @BJSurgery]

Open Access in Oct's BJS: Major surgical postoperative complications and survival in breast cancer: Swedish population-based register study in 57 152 women https://t.co/opL00iKVAa @bplwijn @des_winter @ksoreide @MalinASund @evanscolorectal @nfmkok @robhinchliffe1 @young_bjs

[The Mammary Fold @TheMammaryFold1]

3 days to go until our next webinar.

Don’t miss out on talks by the TIG chair and current and previous oncoplastic fellows

https://t.co/V6xmsZUlHt